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Abstract
The aim of this study was to investigate wheth-
er cohort differences exist in the prevalence of 
cardiovascular risk factors among older elderly 
from the Bambuí Cohort Study of Aging. Par-
ticipants were those aged 71-81 years at two 
points in time a decade apart: 457 in 1997 (ear-
lier cohort) and 553 in 2008 (recent cohort). The 
prevalence of hypertension (PR = 1.27; 95%CI: 
1.19-1.36) and of diabetes mellitus (PR = 1.39; 
95%CI: 1.06-1.83) was higher in the recent cohort 
compared to the earlier one, regardless of sex. The 
recent cohort had a lower prevalence of smoking 
(PR = 0.58; 95%CI: 0.42-0.80), and lower total 
cholesterol/HDL cholesterol ratio level (PR = 0.85; 
95%CI: 0.80-0.89). There was a 136% increase in 
the pharmacologic treatment of diabetes and a 
56% increase in pharmacologic management of 
hypertension in 2008 in comparison with 1997. 
Overall, the number of cardiovascular risk fac-
tors in the recent cohort remained similar to that 
of the early cohort.
Cardiovascular Diseases; Risk Factors; Aged; Co-
hort Studies
Introduction
Cardiovascular risk factors are associated with the 
leading causes of death in the elderly worldwide. 
Cardiovascular diseases (hypertensive heart dis-
ease, ischaemic heart disease and cerebrovascu-
lar disease) account for 30% of mortality among 
those aged 60 and over in high income coun-
tries and 42.2% in middle income countries 1. 
Projections of the impact of health promotion 
initiatives and health care services on health out-
comes should be sensitive to and thus incorporate 
assumptions about underlying trends in the prev-
alence of conventional cardiovascular risk fac-
tors, such as hypertension, diabetes mellitus, dys-
lipidemia, and smoking in a given population 2,3. 
Trends of cardiovascular risk factors in old age 
have received increased attention, particularly in 
high income countries 4,5,6,7,8.
Nationally representative health surveys in 
high income countries have shown that the prev-
alence of smoking among the elderly is declining 
5,6,7. The prevalence of diabetes mellitus – defined 
by fasting blood glucose levels and/or treatment 
or by history of a medical diagnosis – increased in 
the elderly in the United States, Canada and the 
Netherlands between the decades of 1990 and 
2000 6,7,8; in Sweden changes over ten years were 
minimal 9. In the majority of studies, the preva-
lence of hypertension has been increasing. In the 
United States, the prevalence of hypertension, 
defined as a systolic pressure ≥ 140mmHg and/
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or diastolic pressure ≥ 90mmHg and/or treat-
ment, increased between 1988-1994 and 2003-
2006 7. In Canada and in Sweden, the prevalence 
of self-reported hypertension among the elderly 
increased during the same period 6,9. For dys-
lipidemia there are few national surveys. In the 
United States, the prevalence of total cholesterol 
levels ≥ 240mg/dL decreased sharply among the 
elderly in the last decade 7. In Germany, there was 
a slight increase in total cholesterol levels, which, 
apparently, is due to an increase in HDL choles-
terol levels 5.
Data about trends in cardiovascular risk fac-
tors in the elderly, based on surveys of nationally 
representative samples in middle income coun-
tries, are scarce. In South Korea, the prevalence of 
smoking declined between 1998 and 2005 among 
men, but not among women. The prevalence 
of diabetes mellitus and of hypertension (both 
defined by the mean of biological measures or 
treatment) increased in both sexes between 2001 
and 2005. But the prevalence of dyslipidemia 
(total cholesterol ≥ 240mg/dL) decreased in the 
same period 4. In Brazil, a recent study based on 
a representative sample of nearly 40,000 elderly 
participants of the Brazilian National Household 
Sample Survey (PNAD) demonstrated a gradual 
increase in the prevalence of self-reported hy-
pertension (44%, 49% and 53% in 1998, 2003 and 
2008, respectively) and self-reported diabetes 
(10%, 13% and 16%, respectively). These trends 
persist, even after adjusted for sex, age and num-
ber of physician visits 10.
Recent studies have investigated the exis-
tence of cohort differences (i.e., a generation 
effect) in the prevalence of cardiovascular risk 
factors in the elderly. In this type of study, the 
prevalence of risk factors in the recent cohort (in 
order words, those elderly born most recently) 
are compared with a similarly aged cohort from 
an earlier period or vice versa. One example of 
this type of study was carried out in a rural area 
in England. Results from two waves of data col-
lection of a cohort study of elderly were used. The 
earlier cohort was comprised of those who were 
65 to 69 years old in 1991-1992 and the more re-
cent cohort comprised those who fell within the 
same age rage five years later in 1996-1997 (about 
600 subjects participated in each wave). No dif-
ference in the prevalence of hypertension or of 
diabetes mellitus between the two groups was 
observed, indicating the absence of a genera-
tion effect in what was only a five year interval 11. 
Another study conducted in Finland used a 
similar approach over 20 years. Data from three 
waves of a cohort study – each comprised of 200 
to 300 elderly participants – for the years 1988, 
1996 and 2008 were used. The earliest cohort was 
comprised of those who were 65 to 69 years old in 
1988, and so on. No difference in the prevalence 
of self-reported diabetes or hypertension among 
the cohorts was observed 12.
This study sought to examine whether cohort 
differences exists with regard to the prevalence 
of cardiovascular risk factors among the older el-
derly in the Bambuí Cohort Study of Aging.
Methods
Study design and population
The study was conducted as part of the Bam-
buí Cohort Study of Aging, a population-based 
study conducted in Bambuí, a municipality with 
a population of 15,000, located in the state of 
Minas Gerais, in southeastern Brazil. The Bam-
buí Cohort Study of Aging procedures and the 
health profile of baseline participants have been 
described in detail elsewhere 13,14. Briefly, the 
baseline cohort population consisted of all resi-
dents who were age 60 and over on January 1st, 
1997; they were identified by means of a com-
plete census in the city. Baseline data collection 
was performed in 1997, including a standardized 
interview, blood tests, blood pressure measure-
ments and others. The interview was repeated 
annually and other measures and procedures 
were repeated in selected years 13,14. All baseline 
participants aged 71 to 81 years in 1997 (i.e., born 
from 1916 to 1926), as well as all participants in 
the same age range (i.e, born from 1927 to 1937) 
who participated in the 11th wave – conducted in 
2008 – were included in the present analysis.
The Bambuí cohort study was approved by 
the Ethics Research Committee of the Oswaldo 
Cruz Foundation (Fundação Oswaldo Cruz). Par-
ticipants signed an informed consent form in 
1997 and again in 2008.
Variables and data collection
Cardiovascular risk factors considered in this 
study were smoking, diabetes mellitus, hyperten-
sion, total cholesterol, HDL cholesterol, triglycer-
ides, blood glucose, and treatment for hyperten-
sion or diabetes.
Current smoking information was obtained 
by face to face interview in the subject’s home. 
Blood pressure was measured at the Bambuí 
project field clinic in the early morning, after 
five minutes of rest, and at least 30 minutes after 
consumption of caffeine and/or use of tobacco. 
Three blood pressure measures were obtained at 
least two minutes apart using a standard proto-
col 15. All measurements were taken on the right 
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arm with an appropriate size cuff, using a ran-
dom zero Mercury sphygmomanometer (Tycos 
5097-30; Tycos, Arden, USA) and stethoscope 
(Littmann Cardiology II, USA). Systolic and dia-
stolic blood pressures were registered using as a 
reference the first and the fifth Korotkoff sounds, 
respectively. The first measure was ignored; we 
considered the blood pressure the average of the 
second and third measures.
Blood specimens were collected after a rec-
ommended 12 hour fast. Blood tests were per-
formed at the project’s central laboratory in Belo 
Horizonte. Serum levels of lipids were determined 
by enzymatic methods, using standard assay kits 
(Boehringer Mannhein, Ingelheim am Rhein, 
Germany). All lipid and glucose measures were 
performed using an automated analyzer (Eclipse 
Vitalab; Merck, Schiphol-Rijk, Netherlands). 
Medications used were verified by examining the 
packaging and/or the physician’s prescription 
during the home visit. Medications were cod-
ed according to the Anatomical Therapeutical 
Chemical Index (ATC/DDD Index) 16 and were 
considered antihypertensives if they were classi-
fied in groups ATC: C02 – antihypertensives, C03 
– diuretics, C07 – beta-blockers, C08 – calcium 
channel blockers, and C09 – agents that act on 
the renin-angiotensin system. All diabetes medi-
cations were classified in only one ATC group: 
A10. All measurements in 1997 and 2008 were 
performed in a similar way. The interviewer and 
technicians who measured blood pressure were 
trained and certified by a specialized team. The 
laboratory tests were supervised by credentialed 
clinical pathologists.
Current smokers were those who had smoked 
at least 100 cigarettes in their lifetime and were 
still smokers. Hypertension was defined by sys-
tolic blood pressure ≥ 140mmHg and/or diastolic 
blood pressure ≥ 90mmHg and/or anti-hyper-
tensive treatment 17. Diabetes mellitus was de-
fined by fasting blood glucose ≥ 126mg/dL and/
or treatment 18. The number of cardiovascular 
risk factors was defined by the sum (each = 1) 
of the following: current smoking, hypertension, 
diabetes mellitus and total cholesterol/HDL cho-
lesterol ratio above the mean (≥ 5). None of the 
participants had a history of drug treatment for 
lowering lipids, and none had used these drugs 
during the period in which patients were evalu-
ated. Thus, drugs for lowering cholesterol were 
not included in the present analysis.
Statistical analysis
The statistical analysis was based on prevalence 
ratios (PR) and 95% robust confidence intervals 
(95%CI) estimated by the Poisson regression. 
Those aged 71 to 81 years in 1997 (early cohort) 
were the reference category and those in the 
same age range in 2008 (recent cohort) were the 
exposure group. In the initial analysis, men and 
women were pooled and the PR and 95%CI were 
adjusted for sex. Subsequent analyses were strat-
ified by sex. Statistical analyses were conducted 
using Stata 11.0 statistical software (Stata Corp., 
College Station, USA). All p values were 2-tailed 
(α = 0.05).
Results
Of 492 (1997) and 658 (2008) eligible elderly, 457 
and 553 respectively had complete data for all the 
study variables and were included in the analysis. 
Exclusions were due to absence of blood pres-
sure measures or blood tests. Study participants 
and those who were excluded were similar in 
age in 1997 [mean age (SD) = 75.1 (3.1) and 75.8 
(3.4); p = 0.170], and in 2008 [mean age (SD) = 
75.0 (3.0) and 74.8 (3.2); p = 0.433]. Males and 
females participated similarly in both surveys 
[91% and 94.2% (p = 0.179) and 83.6% and 84.3% 
(p = 0.821), respectively].
The distribution of cardiovascular risk fac-
tors and drug treatment for hypertension and 
diabetes in 1997 and 2008 are shown in Table 1. 
Declines from 1997 to 2008 that were statisti-
cally significant and independent of sex and 
age were observed in the prevalence of smoking 
(PR = 0.58; 95%CI: 0.42-0.80) and in the total cho-
lesterol/HDL cholesterol ratio (PR = 0.85; 95%CI: 
0.80-0.89). Conversely, increases were observed 
from 1997 to 2008 in the prevalence of diabetes 
mellitus (PR = 1.39; 95%CI: 1.06-1.83), and for 
hypertension defined by systolic blood pressure 
≥ 140mmHg and/or diastolic blood pressure ≥ 
90mmHg (PR = 1.21; 95%CI: 1.07-1.37), for hy-
pertension defined by blood pressure measure-
ment and/or treatment (PR = 1.27; 95%CI: 1.19-
1.36), in the use of hypoglycemic agents (PR = 
2.33; 95%CI: 1.59-3.43) and in the use of anti-
hypertensive medications (PR = 1.54; 95%CI: 
1.40-1.70). No other measures had differences 
between the earlier and the recent cohorts that 
were statistically significant.
Total cholesterol/HDL cholesterol ratios were 
lower in 2008 than in 1997 both for men (Table 2) 
(PR = 0.84; 95%CI: 0.77-0.92) and for women 
(Table 3) (PR = 0.84; 95%CI: 0.79-0.90). The prev-
alence of current smoking was lower in the re-
cent than in the early cohort for men (Table 2) 
(PR = 0.41; 95%CI: 0.27-0.62) but not for women 
(PR = 1.05; 95%CI: 0.60-1.84) (Table 3). Statisti-
cally significant increases from 1997 to 2008 
were observed in the prevalence of hypertension 
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defined by the mean of blood pressure mea-
surements and/or treatment for men (PR = 1.37; 
95%CI: 1.19-1.57) and for women (PR = 1.22; 
95%CI: 1.13-1.32); for the use of hypoglycemic 
agents by men (PR = 3.64; 95%CI: 1.72-7.70) and 
by women (PR = 1.92; 95%CI: 1.22-3.00), and for 
the use of anti-hypertensive medications by men 
(PR = 1.93; 95%CI: 1.56-2.40) and by women (PR = 
1.40; 95%CI: 1.26-1.55). A reduction in the preva-
lence of smoking and an increase in the preva-
lence of diabetes mellitus in 2008 compared to 
1997 were observed in men but not among wom-
en. From 1997 to 2008, the prevalence of diabetes 
among women increased from 17% to 21.2%, but 
this difference was not statistically significant.
As shown in Figure 1, 14% of the early cohort 
and 7.8% of the recent cohort had zero cardiovas-
cular risk factors, while 43.6% and 41.1% had two 
or more conventional risk factors, respectively. 
Overall, the number of cardiovascular risk factors 
did not change significantly in 2008 when com-
pared with 1997 (sex-adjusted PR = 1.02; 95%CI: 
0.95-1.09).
Discussion
The results of this study show that the preva-
lence of hypertension and of diabetes mellitus 
was higher in the recent cohort than in the early 
cohort, independent of sex. Conversely, the re-
cent cohort had a lower prevalence of smoking 
and a lower total cholesterol/HDL cholesterol ra-
tio. Other parameters did not differ significantly 
between the early and recent cohorts. Analysis 
revealed a 136% increase in the pharmacologic 
treatment of diabetes and a 56% increase in phar-
macologic management of hypertension from 
1997 to 2008, which is consistent with national 
policies that have expanded access to publicly 
financed treatment of these two conditions 19.
There was an impressive drop in the preva-
lence of smoking in the recent cohort relative 
to the early cohort among men. This finding is 
consistent with the decrease in the prevalence of 
smoking in Brazil 20 and in other countries 21,22 
as a result of public policies and campaigns to re-
Table 1
Distribution of cardiovascular risk factors and drug treatment for hypertension and diabetes by birth cohort. The Bambuí Cohort Study of Aging, 
1997 and 2008.






Sex adjusted PR 
(95%CI) *
Current smoking (%) 17.5 9.8 0.58 (0.42-0.80) **
Total cholesterol in mg/dL [mean (SD)] 229.7 (49.3) 203.2 (41.6) 0.99 (0.93-1.05)
HDL cholesterol in mg/dL [mean (SD)] 51.1 (17.3) 49.4 (12.5) 0.98 (0.92-1.05)
Total cholesterol/HDL cholesterol ratio [mean (SD)] 4.9 (1.7) 4.3 (1.3) 0.85 (0.80-0.89) **
Triglycerides in mg/dL [median (IQR)] 127 (93-175) 125 (90-172) 1.00 (0.93-1.06)
Blood glucose in mg/dL [median (IQR)] 98 (90-110) 97 (89-111) 0.98 (0.92-1.05)
Blood glucose ≥ 126 mg/dL (%) 13.4 15.4 1.15 (0.84-1.56)
Diabetes mellitus (blood glucose ≥ 126mg/dL and/or treatment) (%) 14.9 20.8 1.39 (1.06-1.83) ***
Systolic blood pressure in mmHg [mean (SD)] 139.0 (22.9) 142.8 (21.9) 1.00 (0.93-1.06)
Diastolic blood pressure in mmHg [mean (SD)] 81.5 (12.8) 78.9 (11.7) 0.98 (0.92-1.05)
Hypertension (systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure 
≥ 90 mmHg) 
45.3 55.2 1.21 (1.07-1.37) #
Hypertension (systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure 
≥ 90 mmHg and/or treatment)
68.1 87.0 1.27 (1.19-1.36) **
Drug treatment for diabetes (%) 7.0 16.5 2.33 (1.59-3.43) **
Drug treatment for hypertension (%) 50.8 79.0 1.54 (1.40-1.70) **
IQR: interquartile range; SD: standard deviation.
* PR (95%CI): prevalence ratio and 95% robust confi dence interval estimated by Poisson regression. The 1916-1926 cohort was the reference group. 
The prevalence ratios were computed for a 10 percentile unit increment for total cholesterol, total cholesterol/HDL cholesterol ratio, triglycerides, and systolic 
blood pressure. All other variables compared presence vs. absence;
** p < 0.001;
*** p < 0.05;
# p < 0.01.
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Table 2
Distribution of cardiovascular risk factors and drug treatment for hypertension and diabetes among men by birth cohort. The Bambuí Cohort Study of Aging, 
1997 and 2008.







Current smoking (%) 33.2 13.6 0.41 (0.27-0.62) **
Total cholesterol in mg/dL [mean (SD)] 217.8 (48.5) 187.9 (35.1) 0.91 (0.81-1.03)
HDL cholesterol in mg/dL [mean (SD)] 48.3 (18.5) 45.8 (11.8) 0.93 (0.83-1.05)
Total cholesterol/HDL cholesterol ratio [mean (SD)] 5.0 (1.8) 4.3 (1.2) 0.84 (0.77-0.92) **
Triglycerides in mg/dL [median (IQR)] 109 (81-152) 112 (80-154) 1.05 (0.93-1.19)
Blood glucose in mg/dL [median (IQR)] 97 (91-108) 96 (89-112) 0.99 (0.89-1.11)
Blood glucose > 126 mg/dL, % 11.1 15.1 1.36 (0.80-2.32)
Diabetes mellitus (blood glucose ≥ 126mg/dL and/or treatment) (%) 11.6 20.1 1.73 (1.06-2.82) ***
Systolic blood pressure in mmHg [mean (SD)] 137.6 (23.0) 140.9 (20.7) 0.99 (0.88-1.10)
Diastolic blood pressure in mmHg [mean (SD)] 82.3 (13.6) 80.3 (11.4) 1.01 (0.91-1.12)
Hypertension (systolic blood pressure ≥ 140mmHg and/or diastolic blood pressure 
≥ 90mmHg) 
41.4 50.3 1.21 (0.97-1.51)
Hypertension (systolic blood pressure ≥ 140mmHg and/or diastolic blood pressure 
≥ 90mmHg and/or treatment)
59.1 80.9 1.37 (1.19-1.57) **
Drug treatment for diabetes (%) 4.4 16.1 3.64 (1.72-7.70) **
Drug treatment for hypertension (%) 35.9 69.4 1.93 (1.56-2.40) **
IQR: interquartile range; SD: standard deviation.
* PR (95%CI): prevalence ratio and 95% robust confi dence interval estimated by Poisson regression. The 1916-1926 cohort was the reference group. 
The prevalence ratios were computed for a 10 percentile unit increment for total cholesterol, Total cholesterol/HDL cholesterol ratio, triglycerides, and systolic 
blood pressure. All other variables compared presence vs. absence;
** p < 0.001;
*** p < 0.05.
duce smoking. In Brazil the prevalence of smok-
ing in the adult population declined from 35% in 
1989 to 22% in 2003 and 16% in 2009 20,23. Among 
the elderly, this decline was even more striking 
over the same 20 year period: 25%, 15% and 8%, 
respectively. 20,23.
The increase in the prevalence of hyperten-
sion in the recent cohort when compared to the 
early cohort is consistent with findings of nation-
al surveys in various countries 4,6,7,9, and in Bra-
zil 10, suggesting an increase in the prevalence of 
hypertension in the elderly in recent years. How-
ever, it is important to note that these trends may 
be influenced by what criteria are adopted to de-
fine hypertension. In the majority of the above 
mentioned studies, this increase was observed 
for self-reported hypertension (i.e., based on the 
patient reporting a history of a medical diagnosis 
of hypertension) 6,9,10, that could be influenced 
by the expanded use of health services resulting 
in a greater probability of a diagnosis being made. 
Nevertheless, in the United States 7 and in South 
Korea 4 a real increase in the prevalence of hyper-
tension (defined by objective measures of blood 
pressure and/or the use of anti-hypertensive 
medications) were observed, as was in the pres-
ent study. A second definition was used in the 
American study mentioned above. That study, 
based only on blood pressure measures (systolic 
pressure ≥ 140mmHg and/or diastolic pressure 
≥ 90mmHg), disregarded the use of medication, 
and found a reduction in the prevalence of hyper-
tension both among “young elderly” and among 
the “older elderly” from 1988-1994 to 2003-2006 7. 
In the present study, using these same criteria, a 
greater prevalence of hypertension was observed 
in 2008 compared to 1997. The majority of na-
tional surveys conducted in high income coun-
tries 6,7,8 and, more recently, in South Korea 4 and 
in Brazil 10 have found an increase in the preva-
lence of diabetes mellitus in the elderly. However, 
the criteria used to define the presence of diabe-
tes in these studies vary considerably and include 
self-reported morbidity, blood glucose levels, use 
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of hypoglycemic agents, or the combination of 
two or more criteria. In the present study, based 
on a narrower definition of diabetes (fasting glu-
cose and/or treatment), the prevalence of diabe-
tes was 40% higher in the recent cohort relative 
to the early cohort. As mentioned previously, few 
national surveys have examined dyslipidemia 
trends in the elderly population.
Results from the U.S. National Health and 
Nutrition Examination Surveys found a reduction 
in the prevalence of high levels of total cholester-
ol 7. In Germany, a national survey found a slight 
increase in total cholesterol in the elderly, which 
was accompanied by an increase in HDL choles-
terol 5. As lower levels of HDL cholesterol in the 
elderly are more strongly associated than other 
lipid parameters with cardiovascular disease 24 
and with the incidence of hypertension 25,26, the 
increase in HDL cholesterol should offset the in-
crease in total cholesterol 5. In the present study, 
a significant reduction in the total cholesterol/
HDL cholesterol ratio was seen in 2008 relative 
to 1997.
There is evidence from longitudinal stud-
ies that the coexistence of risk factors increases 
cardiovascular risk 27,28,29. About 40% of both 
cohorts had at least two concomitant risk fac-
tors. Additionally, no differences in the number 
of cardiovascular risk factors from 1997 to 2008 
were observed.
Strengths of this study include the communi-
ty-based sample, the standardized and system-
atic measures of parameters at baseline and at 
the 11th wave. Other strengths include the high 
response rate at baseline and minimal loss of 
participants to follow-up 13,14, reducing the like-
lihood of a selection bias in 1997 or in 2008. It 
should be noted, however, that this analysis was 
based on two studies of prevalence and it not 
possible to know whether the changes observed 
were due to changes in the incidence of investi-
gated conditions or their duration.
In summary, the results of the present study 
revealed cohort differences in the cardiovascular 
risk factors in the population studied. Although 
some improvements have been observed – mainly 
Table 3
Distribution of cardiovascular risk factors and drug treatment for hypertension and diabetes among women by birth cohort. The Bambuí Cohort Study of 
Aging, 1997 and 2008.







Current smoking (%) 7.3 7.6 1.05 (0.60-1.84)
Total cholesterol in mg/dL [mean (SD)] 237.6 (48.3) 211.8 (42.6) 1.02 (0.95-1.10)
HDL cholesterol in mg/dL [mean (SD)] 52.9 (16.3) 51.5 (12.4) 1.00 (0.93-1.08)
Total cholesterol/HDL cholesterol ratio [mean (SD)] 4.9 (1.7) 4.3 (1.4) 0.84 (0.79-0.90) **
Triglycerides in mg/dL [median (IQR)] 136 (103-183.5) 132 (97-185) 0.97 (0.90-1.04)
Blood glucose in mg/dL [median (IQR)] 99 (90-112.5) 97 (89-111) 0.97 (0.89-1.06)
Blood glucose ≥ 126 mg/dL (%) 14.9 15.5 1.05 (0.72-1.52)
Diabetes mellitus (blood glucose ≥ 126mg/dL and/or treatment) (%) 17.0 21.2 1.24 (0.90-1.73)
Systolic blood pressure in mmHg [mean (SD)] 140.0 (22.8) 143.9 (22.5) 1.00 (0.92-1.09)
Diastolic blood pressure in mmHg [mean (SD)] 80.9 (12.3) 78.2 (11.8) 0.96 (0.88-1.05)
Hypertension (systolic blood pressure ≥ 140mmHg and/or diastolic blood 
pressure ≥ 90mmHg) 
47.8 57.9 1.21 (1.04-1.41) ***
Hypertension (systolic blood pressure ≥ 140mmHg and/or diastolic blood 
pressure ≥ 90mmHg and/or treatment)
73.9 90.4 1.22 (1.13-1.32) **
Drug treatment for diabetes (%) 8.7 16.7 1.92 (1.22-3.00) #
Drug treatment for hypertension (%) 60.5 84.5 1.40 (1.26-1.55) **
IQR: interquartile range; SD: standard deviation.
* PR (95%CI): prevalence ratio and 95% robust confi dence interval estimated by Poisson regression. The 1916-1926 cohort was the reference group. 
The prevalence ratios were computed for a 10 percentile unit increment for total cholesterol, total cholesterol/HDL cholesterol ratio, triglycerides, and systolic 
blood pressure. All other variables compared presence vs. absence;
** p < 0.001;
*** p < 0.05;
# p < 0.01.
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the decline in smoking, increased treatment of 
hypertension and diabetes, and lower total cho-
lesterol/HDL cholesterol ratio – the overall car-
diovascular risk of the recent cohort remained 
similar to that of the early cohort.
Figure 1
Number of cardiovascular risk factors in the early and recent cohorts. The Bambuí Cohort Study of Aging, 1997 and 2008.
* Cardiovascular risk factors considered were: current smoking, hypertension, diabetes mellitus and total cholesterol/HDL 
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Resumo
O objetivo deste estudo foi investigar se existem di-
ferenças de coorte na prevalência de fatores de risco 
cardiovasculares entre idosos mais velhos do Estudo 
de Coorte de Idosos de Bambuí. Os participantes fo-
ram indivíduos com idade de 71 a 81 anos, em dois 
momentos do tempo, com o intervalo de uma década: 
457 em 1997 (coorte anterior) e 553 em 2008 (coorte re-
cente). A prevalência de hipertensão (RP = 1,27; IC95%: 
1,19-1,36) e de diabetes mellitus (RP = 1,39; IC95%: 
1,06-1,83) foi maior na coorte recente em relação à an-
terior, independentemente do sexo. A coorte recente te-
ve menor prevalência de tabagismo (RP = 0,58; IC95%: 
0,42-0,80) e nível mais baixo da razão colesterol total/
colesterol HDL (RP = 0,85; IC95%: 0,80-0,89). Houve 
um aumento de 136% no tratamento farmacológico 
do diabetes e um aumento de 56% no tratamento far-
macológico da hipertensão em 2008 em comparação 
com 1997. No geral, o número de fatores de risco car-
diovascular na coorte recente permaneceu semelhante 
ao da coorte inicial. 
Doenças Cardiovasculares; Fatores de Risco; Idoso; Es-
tudos de Coortes
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